Moderate cerebral infarction can be treated. Cerebral infarction is caused by the sudden interruption of blood flow in cerebral blood vessels due to various reasons, which results in ischemia and necrosis of brain cells, and the formation of neurological deficits. In the early stage, we need to try our best to restore blood supply to the blocked blood vessels, improve the symptoms of ischemia and hypoxia, and reduce the symptoms of neurological impairment. Clinically, patients should seek early medical treatment, if there is no contraindication to thrombolysis, patients can be treated with thrombolytic drugs.1, thrombolytic drug selection, within 6 hours of the onset of the disease can be used rt-PA, urokinase for intravenous thrombolysis. If the thrombus in the blood vessel is dissolved, the patient’s symptoms can be completely recovered without any sequelae. However, missing the time window for thrombolysis should also be treated actively, and other blood-activating and stasis-eliminating protocols should be applied to improve the blood supply to the ischemic hemidiaphragm around the patient’s necrotic brain tissue and to alleviate the patient’s symptoms. In the clinic, the treatment can be carried out through anticoagulation, anti-platelet aggregation, and fiber-lowering program, and at the same time, edaravone should be given to promote the recovery of cerebral nerve function.